Cochlear CHEOF Stock
Cochlear Price Chart
Cochlear CHEOF Financial and Trading Overview
| Cochlear stock price | 81.92 USD |
| Previous Close | 86.08 USD |
| Open | 86.08 USD |
| Bid | 81.81 USD x 30000 |
| Ask | 86.31 USD x 40000 |
| Day's Range | 86.08 - 86.08 USD |
| 52 Week Range | 64.39 - 207.71 USD |
| Volume | 100 USD |
| Avg. Volume | 1.57K USD |
| Market Cap | 5.63B USD |
| Beta (5Y Monthly) | 0.259 |
| PE Ratio (TTM) | 23.7135 |
| EPS (TTM) | 3.64 USD |
| Forward Dividend & Yield | 2.91 (3.38%) |
| Ex-Dividend Date | March 19, 2026 |
| 1y Target Est | N/A |
CHEOF Valuation Measures
| Enterprise Value | 5.41B USD |
| Trailing P/E | 23.7135 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.4073288 |
| Price/Book (mrq) | 4.1794534 |
| Enterprise Value/Revenue | 2.315 |
| Enterprise Value/EBITDA | 9.634 |
Trading Information
Cochlear Stock Price History
| Beta (5Y Monthly) | 0.259 |
| 52-Week Change | -58.55% |
| S&P500 52-Week Change | 20.84% |
| 52 Week High | 207.71 USD |
| 52 Week Low | 64.39 USD |
| 50-Day Moving Average | 73.95 USD |
| 200-Day Moving Average | 141.47 USD |
CHEOF Share Statistics
| Avg. Volume (3 month) | 1.57K USD |
| Avg. Daily Volume (10-Days) | 3.23K USD |
| Shares Outstanding | 65.4M |
| Float | 65.15M |
| Short Ratio | N/A |
| % Held by Insiders | 0.63% |
| % Held by Institutions | 57.43% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 4.3 |
| Trailing Annual Dividend Yield | 4.99% |
| 5 Year Average Dividend Yield | 143.00% |
| Payout Ratio | 0.8151 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | 14.76% |
| Operating Margin (ttm) | 21.61% |
| Gross Margin | 72.76% |
| EBITDA Margin | 24.03% |
Management Effectiveness
| Return on Assets (ttm) | 11.27% |
| Return on Equity (ttm) | 18.14% |
Income Statement
| Revenue (ttm) | 2.34B USD |
| Revenue Per Share (ttm) | 35.75 USD |
| Quarterly Revenue Growth (yoy) | -0.40% |
| Gross Profit (ttm) | 1.7B USD |
| EBITDA | 562M USD |
| Net Income Avi to Common (ttm) | 345.3M USD |
| Diluted EPS (ttm) | 3.63 |
| Quarterly Earnings Growth (yoy) | -21.30% |
Balance Sheet
| Total Cash (mrq) | 187.1M USD |
| Total Cash Per Share (mrq) | 2.86 USD |
| Total Debt (mrq) | 242.2M USD |
| Total Debt/Equity (mrq) | 12.5 USD |
| Current Ratio (mrq) | 2.456 |
| Book Value Per Share (mrq) | 20.595995 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 264.5M USD |
| Levered Free Cash Flow (ttm) | 104.08M USD |
Profile of Cochlear
| Country | United States |
| State | NSW |
| City | Sydney |
| Address | 1 University Avenue |
| ZIP | 2109 |
| Phone | 61 2 9428 6555 |
| Website | https://www.cochlear.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 5500 |
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
Q&A For Cochlear Stock
What is a current CHEOF stock price?
Cochlear CHEOF stock price today per share is 81.92 USD.
How to purchase Cochlear stock?
You can buy CHEOF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cochlear?
The stock symbol or ticker of Cochlear is CHEOF.
Which industry does the Cochlear company belong to?
The Cochlear industry is Medical Devices.
How many shares does Cochlear have in circulation?
The max supply of Cochlear shares is 65.4M.
What is Cochlear Price to Earnings Ratio (PE Ratio)?
Cochlear PE Ratio is 22.50549300 now.
What was Cochlear earnings per share over the trailing 12 months (TTM)?
Cochlear EPS is 3.64 USD over the trailing 12 months.
Which sector does the Cochlear company belong to?
The Cochlear sector is Healthcare.